Hydrocortisonum Amara

Hydrocortisonum Amara is a topical preparation containing the corticosteroid hydrocortisone acetate. It is supplied in a cream or ointment form (strength not specified) and is marketed in the European Union. The product is used to reduce inflammation and itching associated with various skin conditions. As a glucocorticoid, it works locally on the skin to modulate immune responses. It is intended for short‑term application under medical supervision.

Hydrocortisonum Amara is indicated for several inflammatory and allergic skin disorders where topical anti‑inflammatory therapy is appropriate.

- Mild to moderate atopic dermatitis (eczema) - Contact dermatitis caused by irritants or allergens - Seborrheic dermatitis affecting scalp or face - Psoriasis plaques with limited surface area - Localized allergic skin reactions such as insect bites

Topical hydrocortisone acetate may cause local and, rarely, systemic adverse reactions. Reported effects are grouped by frequency and severity.

Common: - Mild burning or stinging at the site - Transient itching or dryness - Slight redness or irritation - Minor skin thinning with extended use

Serious: - Allergic contact dermatitis to the product - Secondary infection of the treated area - Systemic effects such as adrenal suppression (rare)

Before using Hydrocortisonum Amara, several precautionary measures should be considered to minimize risks.

- Avoid application on broken, infected, or ulcerated skin unless directed by a clinician - Do not use on large body surface areas or for prolonged periods without medical review - Limit use on the face, intertriginous zones, or genital skin due to higher absorption risk - Discontinue if signs of local irritation or allergic reaction develop - Use the lowest effective potency and quantity for the shortest duration needed - Pregnant or breastfeeding individuals should consult a healthcare professional before use

Hydrocortisonum Amara can interact with other topical or systemic agents that affect skin integrity or glucocorticoid activity.

Avoid: - Concurrent use of other potent topical corticosteroids on the same area - Application of occlusive dressings that increase systemic absorption - Use with topical calcineurin inhibitors on compromised skin

Use with caution: - Systemic glucocorticoids or immunosuppressants may increase risk of systemic effects - Antifungal or antibacterial creams applied to the same site may alter local flora - Phototherapy or UV exposure may enhance skin thinning